SZ 469 (Glimepiride and Pioglitazone Hydrochloride 4 mg / 30 mg (base))

Pill with imprint SZ 469 is White, Elliptical / Oval and has been identified as Glimepiride and Pioglitazone Hydrochloride 4 mg / 30 mg (base). It is supplied by Sandoz Inc..

Glimepiride/pioglitazone is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Glimepiride/pioglitazone 4 mg / 30 mg (base) is not a controlled substance under the Controlled Substances Act (CSA).

Images for SZ 469

Glimepiride and Pioglitazone Hydrochloride

Imprint

SZ 469

Strength

4 mg / 30 mg (base)

Color

White

Shape

Elliptical / Oval

Availability

Prescription only

Drug Class

Antidiabetic combinations

Pregnancy Category

C - Risk cannot be ruled out

CSA Schedule

Not a controlled drug

Labeler / Supplier

Sandoz Inc.

National Drug Code (NDC)

00781-5635

More Info Imprint Search Print

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer